PMID: 6979379Jul 1, 1982Paper

T-cell lymphoblastic lymphoma with subsequent acute nonlymphocytic leukemia: a case report

Cancer
M R PosnerA T Skarin

Abstract

A case of T-cell lymphoblastic lymphoma is described in which the patient presented with a characteristic mediastinal mass and lack of bone marrow involvement. Immunologic studies of the surface phenotype of the malignant cells in a pleural effusion with monoclonal antibodies revealed the cells to be of thymic origin and distinguished them from the surface phenotypes seen in T-cell acute lymphoblastic leukemia. Twenty-five months after presentation with lymphoma, the patient developed an acute nonlymphocytic leukemia. With the improved prognosis seen in lymphoblastic lymphoma with intensive combination chemotherapy, it is expected that more cases of subsequent acute nonlymphocytic leukemia will be seen. In view of the natural history of lymphoblastic lymphoma to develop into lymphoblastic leukemia, it is important to be alert to a complicating nonlymphocytic leukemia.

References

Apr 26, 1975·Lancet·G P CanellosR E Johnson
Jan 1, 1979·Medicine·D A Casciato, J L Scott
Aug 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·E L ReinherzS F Schlossman
Oct 4, 1979·The New England Journal of Medicine·D E BergsagelA B Miller
Dec 8, 1977·The New England Journal of Medicine·C N ColemanH S Kaplan
Aug 1, 1976·Cancer·B N NathwaniH Rappaport
Oct 1, 1973·The Journal of Clinical Investigation·K A AultE R Unanue
Apr 1, 1980·Cell·E L Reinherz, S F Schlossman

❮ Previous
Next ❯

Citations

Dec 1, 1993·Leukemia & Lymphoma·A ChubachiA B Miura
Mar 17, 2010·Human Pathology·Courtney C JacksonRoberto N Miranda
Jun 1, 1985·Cancer Treatment Reviews·T Henne, D Schmähl
Mar 20, 2001·Hematology/oncology Clinics of North America·D A Thomas, H M Kantarjian

❮ Previous
Next ❯

Related Concepts

Related Feeds

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.